Literature DB >> 24336336

Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients.

S Kelly1, F Humby2, A Filer3, N Ng2, M Di Cicco2, R E Hands2, V Rocher2, M Bombardieri2, M A D'Agostino4, I B McInnes5, C D Buckley2, P C Taylor6, C Pitzalis2.   

Abstract

OBJECTIVE: To determine the tolerability, safety and yield of synovial tissue in an early arthritis cohort using a minimally invasive, ultrasound (US)-guided, synovial biopsy technique in small, medium and large joints.
METHODS: 93 sequential biopsy procedures were assessed from a total of 57 patients (baseline and 36 repeat biopsies at 6 months) recruited as part of the 'Pathobiology of Early Arthritis Cohort' study. Patients completed a tolerability questionnaire prior to and following the synovial biopsy procedure. The synovial biopsy was performed under US guidance with US images of the joint recorded prior to each procedure. Synovial tissue was harvested for immunohistochemistry and RNA extraction.
RESULTS: Five different joint sites were biopsied (knee, elbow, wrist, metacarpal phalangeal and proximal interphalangeal). No significant complications were reported following the procedure. No difference in pain, swelling and stiffness of the biopsied joint from before and after the procedure was demonstrated. A median of 14 biopsy samples was retrieved from each procedure with 93% of biopsy procedures yielding good quality tissue. RNA yield was good in all joints and in repeat biopsies. Multivariant analysis demonstrated a significantly greater yield of RNA and graded tissue in relation to a high prebiopsy, grey-scale synovitis score (0-3, semiquantitative).
CONCLUSIONS: A minimally invasive approach to synovial tissue harvesting, using US guidance, is both safe and well-tolerated by patients. Tissue quality/RNA yield is preserved in subsequent biopsies following therapeutic intervention. A high US grey-scale synovitis score is a predictor of good quality/quantity of tissue and RNA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Early Rheumatoid Arthritis; Inflammation; Synovitis; Ultrasonography

Mesh:

Substances:

Year:  2013        PMID: 24336336     DOI: 10.1136/annrheumdis-2013-204603

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  62 in total

Review 1.  Ultrasound-guided synovial biopsy.

Authors:  Jacqueline C M Sitt; James F Griffith; Priscilla Wong
Journal:  Br J Radiol       Date:  2015-11-02       Impact factor: 3.039

2.  HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness.

Authors:  David Kuo; Jennifer Ding; Ian S Cohn; Fan Zhang; Kevin Wei; Deepak A Rao; Cristina Rozo; Upneet K Sokhi; Sara Shanaj; David J Oliver; Adriana P Echeverria; Edward F DiCarlo; Michael B Brenner; Vivian P Bykerk; Susan M Goodman; Soumya Raychaudhuri; Gunnar Rätsch; Lionel B Ivashkiv; Laura T Donlin
Journal:  Sci Transl Med       Date:  2019-05-08       Impact factor: 17.956

Review 3.  Immune cell profiling to guide therapeutic decisions in rheumatic diseases.

Authors:  Joerg Ermann; Deepak A Rao; Nikola C Teslovich; Michael B Brenner; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

4.  Ultrasound-guided synovial biopsy improves diagnosis of septic arthritis in acute arthritis without enough analyzable synovial fluid: a retrospective analysis of 176 arthritis from a French rheumatology department.

Authors:  Guillaume Coiffier; Marine Ferreyra; Jean-David Albert; Nathalie Stock; Anne Jolivet-Gougeon; Aleth Perdriger; Pascal Guggenbuhl
Journal:  Clin Rheumatol       Date:  2018-06-14       Impact factor: 2.980

5.  Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study.

Authors:  David L Boyle; Samuel E DePrimo; Cesar Calderon; Dion Chen; Paul J Dunford; William Barchuk; Gary S Firestein; Robin L Thurmond
Journal:  Inflamm Res       Date:  2019-02-09       Impact factor: 4.575

Review 6.  Transforming clinical trials in rheumatology: towards patient-centric precision medicine.

Authors:  Costantino Pitzalis; Ernest H S Choy; Maya H Buch
Journal:  Nat Rev Rheumatol       Date:  2020-09-04       Impact factor: 20.543

7.  Efficacy of image-guided synovial biopsy.

Authors:  T Conor McKee; Jeffrey A Belair; Keenan Sobol; Scot A Brown; John Abraham; William Morrison
Journal:  Skeletal Radiol       Date:  2020-01-07       Impact factor: 2.199

8.  Willie Sutton Was Right: It's Time to Turn to the Synovium to Drive Rheumatoid Arthritis Therapy.

Authors:  Eric M Ruderman; Arthur M Mandelin; Harris R Perlman
Journal:  J Rheumatol       Date:  2016-12       Impact factor: 4.666

9.  Ultrasound-guided synovial Tru-cut biopsy: indications, technique, and outcome in 111 cases.

Authors:  Jacqueline C M Sitt; James F Griffith; Fernand M Lai; Mamie Hui; K H Chiu; Ryan K L Lee; Alex W H Ng; Jason Leung
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

10.  The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.

Authors:  Irene Mattiola; Federica Tomay; Maria De Pizzol; Rita Silva-Gomes; Benedetta Savino; Tamara Gulic; Andrea Doni; Silvia Lonardi; Marie Astrid Boutet; Alessandra Nerviani; Roberta Carriero; Martina Molgora; Matteo Stravalaci; Diego Morone; Irina N Shalova; Yunquin Lee; Subhra K Biswas; Giovanna Mantovani; Marina Sironi; Costantino Pitzalis; William Vermi; Barbara Bottazzi; Alberto Mantovani; Massimo Locati
Journal:  Nat Immunol       Date:  2019-07-01       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.